62 Cases of Myocarditis After Vaccination in Israel... Causality Needs Verification

[Asia Economy Reporter Gong Byung-sun] In Israel, where more than half of the population has received the COVID-19 vaccine, 62 cases of myocarditis have been reported following vaccination.

On the 25th (local time), Israeli local media reported that myocarditis occurred in approximately 1 out of every 86,000 COVID-19 vaccine recipients. Experts have stated that further research is needed to confirm the causal relationship between the vaccine and myocarditis.

Myocarditis is a condition in which inflammation occurs in the heart muscle due to various causes such as viruses, toxins, or immune responses. In many cases, patients recover, but some cases can lead to heart failure or death.

The age group of myocarditis patients reported after vaccination in Israel is between 18 and 30 years old. Among the 62 total myocarditis cases, 56 had completed the second dose. By gender, 55 were male, significantly more than females.

The expert committee entrusted by the Israeli Ministry of Health to monitor adverse reactions to the COVID-19 vaccine explained, "More myocarditis patients were found during the active investigation," and "a more detailed report will be prepared soon."

Israel imported the Pfizer-BioNTech vaccine and conducted nationwide vaccinations. So far, about 5.37 million people have received the first dose, and about 5 million have completed the second dose.

This content was produced with the assistance of AI translation services.